- 专利标题: Immune cells modified by transient transfection of RNA
-
申请号: US15012285申请日: 2016-02-01
-
公开(公告)号: US10017782B2公开(公告)日: 2018-07-10
- 发明人: Peter M. Rabinovich , Sherman M. Weissman , Erkut Bahceci , Marina E. Komarovskaya
- 申请人: Yale University
- 申请人地址: US CT New Haven
- 专利权人: Yale University
- 当前专利权人: Yale University
- 当前专利权人地址: US CT New Haven
- 代理机构: Pabst Patent Group LLP
- 主分类号: A61K9/66
- IPC分类号: A61K9/66 ; C12N15/85 ; A61K48/00 ; C12N5/074 ; A61K35/17 ; A61K35/33 ; A61K35/36 ; A61K35/12
摘要:
RNA prepared by in vitro transcription using a polymerase chain reaction (PCR)-generated template can be introduced into a cell to modulate cell activity. This method is useful in de-differentiating somatic cells to pluripotent, multipotent, or unipotent cells; re-differentiating stem cells into differentiated cells; or reprogramming of somatic cells to modulate cell activities such as metabolism. Cells can also be transfected with inhibitory RNAs, such as small interfering RNA (siRNA) or micro RNA (miRNA), or combinations thereof to induce reprogramming of somatic cells. For example, target cells are isolated from a donor, contacted with one or more RNA's causing the cells to be de-differentiated, re-differentiated, or reprogrammed in vitro, and administered to a patient in need thereof. The resulting cells are useful for treating one or more symptoms of a variety of diseases and disorders, for organ regeneration, and for restoration of the immune system.
公开/授权文献
信息查询